Regents of the University of California’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Regents of the University of California’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-621,541	Closed	-$21M	–	40
2021 Q2	$21M	Hold	621,541	–	–	2.68%	5
2021 Q1	$14.5M	Sell	621,541 -115,865	-16%	-$3.51M	1.9%	6
2020 Q4	$21.2M	Sell	737,406 -500,000	-40%	-$12.6M	3.07%	5
2020 Q3	$25.1M	Hold	1,237,406	–	–	3.49%	4
2020 Q2	$37.2M	Sell	1,237,406 -260,000	-17%	-$9.37M	5.22%	4
2020 Q1	$47.1M	Sell	1,497,406 -250,000	-14%	-$8.69M	7.01%	3
2019 Q4	$82.3M	Sell	1,747,406 -550,000	-24%	-$15.9M	43.41%	1
2019 Q3	$14.8M	Buy	+2,297,406	New	+$19.2M	28.42%	1

Regents of the University of California's CNST Position: Q3 2021 in Review

Regents of the University of California sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 621,541 shares — an estimated $21M sold.

Regents of the University of California first reported a position in CNST in Q3 2019 and held it in 8 quarters. The position peaked at $82.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Regents of the University of California reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Regents of the University of California sold 621,541 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $21M.
Regents of the University of California first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2019 and held it in 8 quarters.
Regents of the University of California's Constellation Pharmaceuticals, Inc. position peaked at $82.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Regents of the University of California's 13F filing for Q3 2021, filed 20 Oct 2021.